Engineering Organoid Platforms for Pathogenesis Research
Research · 01.01.2026 · 9
DOI: 10.34133/research.1346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Research, online erschienen am 04.08.2026. Verfasst von Xiaolu Han und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, 100071 Beijing, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Emerging and re-emerging infectious diseases ranging from the 1918 H1N1 influenza pandemic to the recent SARS-CoV-2 and monkeypox virus outbreaks continue to pose profound threats to global public health. These crises underscore the critical need for high-fidelity and human-relevant infection models. Organoid technology has emerged as a cornerstone platform for pathogen research by faithfully recapitulating the 3-dimensional architecture and physiological microenvironment of native human tissues in vitro. This review systematically examines the development and structural refinement of organoid-based infection models with an emphasis on evidence-based strategies for stem cell source selection, extracellular matrix optimization, and dynamic culture system engineering. Such advancements enable the robust generation of multi-organ models including respiratory, intestinal, and neural organoids tailored for investigating viral tropism, spatiotemporal infection kinetics, and host immune responses. Furthermore, we evaluate the translational utility of organoids in high-throughput antiviral drug screening and preclinical vaccine assessment. To further enhance physiological relevance and functional fidelity, organoid platforms are being increasingly combined with advanced engineering strategies, including coculture approaches, CRISPR–Cas9-mediated genetic perturbation, engineered microphysiological systems (such as organ-on-a-chip), and 3D bioprinting. These integrated technologies improve biomimicry while expanding experimental controllability and scalability. In addition, we critically examine the major bottlenecks limiting clinical translation and discuss emerging frontiers driven by artificial intelligence and synthetic biology. Through iterative technological refinement and cross-disciplinary convergence, organoids have evolved beyond reductionist in vitro surrogates into physiologically informed and mechanism-driven platforms that advance our understanding of host–pathogen interactions while enhancing global preparedness against emerging pathogens.
Autor:innen und Institutionen
- National Key Laboratory of Advanced Biotechnology, Academy of Military Medical Sciences, 100071 Beijing, China.
- School of Life Science and Technology, Harbin Institute of Technology, 150080 Harbin, China.
- Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
ORCID-Profile: Lihua Ding, Xiang Gao
Zitieren
APA
Han, X., Zhang, J., Bai, J., Tian, W., Zhou, J., Ding, L., & Gao, X. (2026). Engineering Organoid Platforms for Pathogenesis Research. Research, 9. https://doi.org/10.34133/research.1346
Vancouver
Han X, Zhang J, Bai J, Tian W, Zhou J, Ding L, et al. Engineering Organoid Platforms for Pathogenesis Research. Research. 2026;9. doi:10.34133/research.1346
BibTeX
@article{Han2026,
author = {Han, Xiaolu and Zhang, Jun and Bai, Jiahui and Tian, Weiming and Zhou, Jie and Ding, Lihua and Gao, Xiang},
title = {Engineering Organoid Platforms for Pathogenesis Research},
journal = {Research},
year = {2026},
volume = {9},
doi = {10.34133/research.1346}
}
EUVIMED